Tripex Pharmaceuticals Overview

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Tripex Pharmaceuticals General Information


Developer of medicinal drugs designed to treat chronic pulmonary infections. The company's medicinal drugs offer an inhaled fluoroquinolone for the management of chronic pulmonary infections, enabling patients to access effective lungs infection treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tripex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 00.000 Completed Startup
1. Early Stage VC 30-Sep-2015 00.000 00.000 Completed Startup
To view Tripex Pharmaceuticals’s complete valuation and funding history, request access »